GILEAD SCIENCES INC's ticker is and the CUSIP is 375558AP8. A total of 59 filers reported holding GILEAD SCIENCES INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $29,813,000 | -26.0% | 7,245,000 | -19.6% | 0.09% | -22.3% |
| Q4 2015 | $40,279,000 | +0.1% | 9,011,000 | -4.0% | 0.12% | 0.0% |
| Q3 2015 | $40,250,000 | -19.8% | 9,385,000 | -3.6% | 0.12% | -8.3% |
| Q2 2015 | $50,214,000 | +14.4% | 9,735,000 | -4.4% | 0.13% | +18.9% |
| Q1 2015 | $43,902,000 | -28.7% | 10,186,000 | -31.5% | 0.11% | -28.8% |
| Q4 2014 | $61,555,000 | -19.2% | 14,866,000 | -8.8% | 0.16% | -18.3% |
| Q3 2014 | $76,141,000 | -49.2% | 16,300,000 | -60.3% | 0.19% | +11.7% |
| Q2 2014 | $149,792,000 | +116.4% | 41,074,000 | +84.7% | 0.17% | +8.2% |
| Q1 2014 | $69,225,000 | -20.5% | 22,241,000 | -15.7% | 0.16% | -18.6% |
| Q4 2013 | $87,054,000 | +12.0% | 26,380,000 | -6.0% | 0.19% | +8.4% |
| Q3 2013 | $77,730,000 | +10.8% | 28,055,000 | -9.4% | 0.18% | +9.8% |
| Q2 2013 | $70,159,000 | – | 30,975,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INCOME RESEARCH & MANAGEMENT | 9,376,000 | $40,393,000 | 6.90% |
| MACKAY SHIELDS LLC | 12,148,000 | $52,358,000 | 2.77% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $6,465,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 6,200,000 | $26,710,000 | 2.53% |
| SSI INVESTMENT MANAGEMENT LLC | 4,620,000 | $19,905,000 | 1.88% |
| CNO Financial Group, Inc. | 500,000 | $2,154,000 | 0.91% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 13,789,000 | $59,376,000 | 0.86% |
| Man Investments (CH) AG | 400,000 | $1,724,000 | 0.83% |
| Lombard Odier Asset Management (Europe) Ltd | 2,380,000 | $10,242,000 | 0.80% |
| CQS Cayman LP | 3,750,000 | $16,252,000 | 0.76% |